Compounds, pharmaceutical compositions, and methods of use are disclosed for heteroaryl amide analogues of formula Ia and/or Ib: . In certain embodiments, the heteroaryl amide analogues are agonists and/or ligands of dopamine receptors and may be useful, inter alia, for the treatment of a condition responsive to P2X7 receptor modulation, for example, pain, inflammation, a neurological or neurodegenerative disorder, a cardiovascular disorder, an ocular disorder or an immune system disorder.
Rapid and Efficient Access to Secondary Arylmethylamines
作者:Nicolas Fleury-Brégeot、Jessica Raushel、Deidre L. Sandrock、Spencer D. Dreher、Gary A. Molander
DOI:10.1002/chem.201200831
日期:2012.7.27
Ammoniomethyl trifluoroborates are very powerful reagents that can be used to access biologically relevant aryl‐ and heteroaryl‐methylamine motifs via Suzuki–Miyaura cross‐couplings. Until now, this method was limited to the production of tertiary and primary amines. The synthesis of a large array of secondary ammoniomethyltrifluoroborates has been achieved through a one step nucleophilic substitution
Photoreduction of imines. An environmentally friendly approach to obtain amines
作者:María Ortega、Miguel A. Rodríguez、Pedro J. Campos
DOI:10.1016/j.tet.2005.09.047
日期:2005.12
The photoreduction of different imines to amines in alcoholic solvents is reported. The reduction involves a versatile and chemoselective methodology that is environmentally friendly in that it avoids the use of metal hydrides and other dangerous reducing agents.
[EN] TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES TRICYCLIQUES, LEURS COMPOSITIONS ET PROCÉDÉS D'UTILISATION
申请人:HOFFMANN LA ROCHE
公开号:WO2011086053A1
公开(公告)日:2011-07-21
The invention provides novel compounds of formula (I) having the general formula, wherein R1, R2, R3, X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.